Eton Pharmaceutcials
ETON
50 hedge funds and large institutions have $63.6M invested in Eton Pharmaceutcials in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 18 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
35% more call options, than puts
Call options by funds: $73K | Put options by funds: $54K
6% more funds holding
Funds holding: 47 → 50 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.05% less ownership
Funds ownership: 36.04% → 35.99% (-0.05%)
9% less capital invested
Capital invested by funds: $70.2M → $63.6M (-$6.57M)
17% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$1.39M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$640K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$422K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$342K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$338K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.33M |
| 2 |
MML Investors Services
Springfield,
Massachusetts
|
-$1M |
| 3 |
AIC
AWM Investment Company
New York
|
-$621K |
| 4 |
JP Morgan Chase
New York
|
-$212K |
| 5 |
Morgan Stanley
New York
|
-$137K |
ETON Hedge Fund Activity: Q1 2021 in Review
50 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q1 2021, worth a combined $63.6M — down 9.4% from $70.2M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ETON positions and 3 closed out — a net gain of 3 holders — while 15 added to existing stakes and 18 trimmed.
The largest buyer was Sio Capital Management, opening a new position worth an estimated $1.39M. The largest seller was Vanguard Group, cutting an estimated $1.33M.
- 50 institutional investors held Eton Pharmaceutcials (ETON) as of Q1 2021, up from 47 in Q4 2020.
- Funds reported $63.6M of Eton Pharmaceutcials stock for Q1 2021, down 9.4% quarter-over-quarter.
- 6 funds opened new Eton Pharmaceutcials positions in Q1 2021 and 3 closed out, a net change of +3 holders.
- The largest Eton Pharmaceutcials buyer in Q1 2021 was Sio Capital Management, an estimated $1.39M added.
- The largest Eton Pharmaceutcials seller in Q1 2021 was Vanguard Group, an estimated $1.33M sold.
Based on aggregated 13F filings for Q1 2021.